St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Location
Kano City, Nigeria
Implementation Period
2023-2025 (2023 Wave)
Scholars Project
Unveiling the Diversities of Beta Globin Gene and Associated Defective MBL2 Gene Variants: as Predictors of Bacteremia among Sickle Cell Disease Children in Kano, Nigeria
Current Role
Medical Laboratory Scientist, Aminu Kano Teaching Hospital, Researcher, Kano Independent Research Centre Trust
Sickle cell disease (SCD) and other hemoglobinopathies are the most prevalent genetic disorders globally. Sub-Saharan Africa bears the highest burden, with Nigeria recording over 150,000 new SCD births annually, making it the most affected country worldwide.
Children with SCD have an increased tendency to bacteremia and other infections. Polymorphism of a mannose-binding lectin gene (MBL2) has been documented as a potential immunogenetic modulating factor that could cause an additional risk of infection in SCD children. Based on this, there is a need for research on genetic modifiers linked to bacteremia and sepsis risk to enable earlier anticipation of the onset and progression of infection among SCD children. Early management can lower the rate of morbidity and death associated with infection and sepsis in children who are considered to be at high risk.
This study, based in Kano, Nigeria, has helped in understanding the clinical, demographic and laboratory correlates/associations between implicating genes and some clinical outcomes, including identifying genetic diversities related to single nucleotide polymorphisms and haplotypes of the candidate genes of interest among SCD children.
Yusuf Danasabe Jobbi’s commitment to science began early in life, shaped by the loss and suffering he witnessed among family members affected by sickle cell disease and other rare genetic conditions. As a child, he grew curious about their diagnoses and wondered whether different treatments might have changed their outcomes. This desire to understand and to prevent similar tragedies evolved into a deep passion for medical laboratory science and hematology.
He earned his bachelor’s degree in medical laboratory science from Usmanu Danfodiyo University in Sokoto, Nigeria, in 2014, followed by a master’s degree in biotechnology from Bayero University in Kano in 2019. In his current role as medical laboratory scientist at Aminu Kano Teaching Hospital, he collaborates with nongovernmental organizations on sickle cell awareness, supervises interns and laboratory staff, develops standard operating procedures, ensures quality control and performs routine hematological analyses for patient care.
“This [genomics approach] is where the world is going. … We evaluate patients based on their blueprints. This is a hereditary disease; this is a genomic disease. So just relying on some other things that are in blood and urine and feces will not give you a better picture.”